The Physicians Committee for Responsible Medicine has petitioned the Department of Agriculture to require a colon cancer warning on labels for processed meats and poultry.
With early detection, some patients with colon cancer might be able to avoid major surgery. (NYU Langone Health)
A review of published research added to the evidence linking vaping to lung cancer, though perhaps indirectly. (The Conversation)
Meanwhile, British public health experts argue that smoking shisha tobacco (hookah) poses as much of a health risk as smoking regular cigarettes. (The BMJ)
A large case-control study failed to uncover evidence linking breast cancer susceptibility genes to increased breast tissue density, a recognized breast cancer risk factor. (Lancet Obstetrics, Gynaecology & Women’s Health)
The FDA granted full approval to the CAR T-cell therapy brexucabtagene autoleucel (Tecartus) for relapsed/refractory mantle cell lymphoma, Gilead and Kite Oncology announced.
Just in time for Cancer Prevention and Early Detection Month: Cost now rivals fear of cancer as a principal reason for missing recommended cancer screenings. (Prevent Cancer Foundation)
An investigational test for bile duct cancer doubled the rate of detection observed with currently available tests. (University of Pittsburgh Medical Center)
Integrating artificial intelligence (AI) into routine mammographic screening could greatly improve early detection of breast cancer. (ASCO AI in Oncology)
Robotic-assisted bronchoscopy could make lung cancer diagnosis faster and safer. (Mayo Clinic)
Surgery for early-stage lung cancer appears safe for many patients ages 80 and older. (Icahn School of Medicine at Mount Sinai)
A pro-inflammatory molecule that drives psoriasis and other inflammatory conditions might also be a principal driver of breast cancer metastasis, creating potential for a new approach to treatment. (UC San Diego)
Recent Medicare billing code changes for radiation oncology pose a “serious and immediate threat to cancer care in the United States,” according to the American Society for Radiation Oncology.
A 43-year-old British woman brushed off her shrinking breast as a pregnancy-related symptom. It wasn’t. (People)
A randomized trial showed that a three-drug combination that included durvalumab (Imfinzi), plus transarterial chemoembolization (TACE), significantly improved progression-free survival in hepatocellular carcinoma versus TACE alone, AstraZeneca announced.
The popular supplement vitamin B3 may blunt the effectiveness of chemotherapy for pancreatic cancer. (Case Western Reserve University)
Can “playful” acronyms for cancer trials be too playful? (Oncology News Central)
Source: Read Full Article
